Literature DB >> 9688022

The familial periodic paralyses and nondystrophic myotonias.

L Ptácek1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9688022     DOI： 10.1016/s0002-9343(98)00123-5

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  14 in total

Review 1.  Ion channel genes and human neurological disease: recent progress, prospects, and challenges.

Authors:  E C Cooper; L Y Jan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  A1152D mutation of the Na+ channel causes paramyotonia congenita and emphasizes the role of DIII/S4-S5 linker in fast inactivation.

Authors:  Magali Bouhours; Sandrine Luce; Damien Sternberg; Jean Claude Willer; Bertrand Fontaine; Nacira Tabti
Journal:  J Physiol       Date:  2005-03-24       Impact factor: 5.182

3.  Increased rigidity of the chiral centre of tocainide favours stereoselectivity and use-dependent block of skeletal muscle Na(+) channels enhancing the antimyotonic activity in vivo.

Authors:  S Talon; A De Luca; M De Bellis; J F Desaphy; G Lentini; A Scilimati; F Corbo; C Franchini; P Tortorella; H Jockusch; D Conte Camerino
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

4.  Colocalization and coassembly of two human brain M-type potassium channel subunits that are mutated in epilepsy.

Authors:  E C Cooper; K D Aldape; A Abosch; N M Barbaro; M S Berger; W S Peacock; Y N Jan; L Y Jan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

5.  An interactive voice response diary for patients with non-dystrophic myotonia.

Authors:  Jeffrey M Statland; Yunxia Wang; Rachel Richesson; Brian Bundy; Laura Herbelin; Joe Gomes; Jaya Trivedi; Shannon Venance; Anthony Amato; Michael Hanna; Robert Griggs; Richard J Barohn
Journal:  Muscle Nerve       Date:  2011-07       Impact factor: 3.217

6.  Functional characterization and cold sensitivity of T1313A, a new mutation of the skeletal muscle sodium channel causing paramyotonia congenita in humans.

Authors:  Magali Bouhours; Damien Sternberg; Claire-Sophie Davoine; Xavier Ferrer; Jean Claude Willer; Bertrand Fontaine; Nacira Tabti
Journal:  J Physiol       Date:  2003-11-14       Impact factor: 5.182

7.  Increased hindrance on the chiral carbon atom of mexiletine enhances the block of rat skeletal muscle Na+ channels in a model of myotonia induced by ATX.

Authors:  J F Desaphy; D Conte Camerino; C Franchini; G Lentini; V Tortorella; A De Luca
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

8.  Evaluation of the pharmacological activity of the major mexiletine metabolites on skeletal muscle sodium currents.

Authors:  M De Bellis; A De Luca; F Rana; M M Cavalluzzi; A Catalano; G Lentini; C Franchini; V Tortorella; D Conte Camerino
Journal:  Br J Pharmacol       Date:  2006-08-21       Impact factor: 8.739

Review 9.  Drug treatment for myotonia.

Authors:  J Trip; G Drost; B G M van Engelen; C G Faber
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

Review 10.  Taurine and skeletal muscle disorders.

Authors:  Diana Conte Camerino; Domenico Tricarico; Sabata Pierno; Jean-François Desaphy; Antonella Liantonio; Michael Pusch; Rosa Burdi; Claudia Camerino; Bodvael Fraysse; Annamaria De Luca
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.